Diphemanil Methyl Sulfate Production Cost Reports

The report provides a detailed analysis essential for establishing a diphemanil methyl sulfate production plant. It encompasses all critical aspects necessary for diphemanil methyl sulfate production, including the cost of diphemanil methyl sulfate production, diphemanil methyl sulfate plant cost, diphemanil methyl sulfate production costs, and the overall diphemanil methyl sulfate production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a diphemanil methyl sulfate production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Diphemanil methyl sulfate is a synthetic pharmaceutical compound that is mainly used in the healthcare and medical sectors. It is primarily utilised as an anticholinergic drug to help manage conditions related to excessive stomach and intestinal activity. It finds its main application in the treatment of gastrointestinal disorders such as ulcers, irritable bowel problems, and spasms by reducing muscle contractions and controlling acid secretion. It is also used as an effective parasympatholytic agent in the treatment of peptic ulcer disease, where it reduces gastric acid secretion and gastrointestinal hypermotility. It is also used in the management of hyperhidrosis, which is a condition characterised by excessive sweating. It works by blocking certain nerve signals that trigger sweat glands. It is also used to relieve symptoms like abdominal cramps and discomfort caused by overactive digestive movements. In some cases, it is used before surgery to help dry up bodily fluids and keep airways clear.

The market for diphemanil methyl sulfate is driven by its application as an anticholinergic in the treatment of hyperhidrosis and Frey's syndrome, which significantly boosts its demand in the medical sector. Its application as a medication in the treatment of stomach and intestinal disorders, where reducing fluid secretion is required, such as peptic ulcers, further boosts its demand in the pharmaceutical industry. Its usage as an oral drug to decrease sweat gland activity for the treatment of conditions like hyperhidrosis and Frey's syndrome further drives its demand in the medical and pharmaceutical industries. Its demand in the production of specific medicinal formulations and in clinical research focused on digestive and antispasmodic treatments also contributes to its market growth.

Moreover, its utility in reducing certain body secretions during specific medical treatments further contributes to its demand in clinical settings. Various factors, such as the cost and availability of chemical intermediates, regulatory approvals, quality compliance requirements, and safety standards, significantly impact industrial diphemanil methyl sulfate procurement. Furthermore, improvements in pharmaceutical production processes, dependable supplier networks, sustainability initiatives, and efficient distribution systems also impact its procurement practices.

Raw Material for Diphemanil Methyl Sulfate Production

According to the diphemanil methyl sulfate production plant project report, the major raw materials for diphemanil methyl sulfate production include bromobenzene, magnesium, 4-benzoyl-N-methylpiperidine, concentrated sulfuric acid, and dimethyl sulfate.

Production Process of Diphemanil Methyl Sulfate

The extensive diphemanil methyl sulfate production cost report consists of the following industrial production process:

1. Production via Chemical Synthesis: The production process of diphemanil methyl sulfate begins with the preparation of diphenyl-(N-methyl-4-piperidyl)carbinol through a Grignard reaction between bromobenzene and 4-benzoyl-N-methylpiperidine in anhydrous ether. After completion of the reaction, the mixture is decomposed, and the desired carbinol is isolated from the organic layer and purified. Then, this intermediate is dehydrated using concentrated sulfuric acid to form diphenyl-(N-methyl-4-piperidylidene)methane, which is recovered after neutralisation and extraction. In the final step, the resulting tertiary amine is reacted with dimethyl sulfate to quaternize the nitrogen, which forms diphemanil methyl sulfate as the final quaternary ammonium salt after purification.

Diphemanil Methyl Sulfate is a synthetic quaternary ammonium anticholinergic agent that binds to muscarinic acetylcholine receptors, thereby decreasing the secretory excretion of stomach acids, saliva, and sweat. It appears as a white to almost white powder or crystalline solid that is soluble in water and is hygroscopic in nature. The molecular formula of the compound is C21H27NO4S, and its molar mass is 389.51 g/mol. The compound has a melting point of 194–195 degree Celsius and is soluble in water as well as in DMSO. It is marketed under the brand name Prantal. The drug is not well absorbed from the gastrointestinal tract, particularly in the presence of food, and should therefore be administered between meals. The compound is classified as harmful if swallowed, and it may cause skin and eye irritation upon direct contact. It is recommended to wear protective clothing, gloves, and eye protection while handling the compound. The compound should be stored under an inert atmosphere in a freezer below -20 degree Celsius.